Quantum Biopharma (QNTM) Long-Term Investments (2018 - 2025)

Quantum Biopharma (QNTM) has 8 years of Long-Term Investments data on file, last reported at $2224.0 in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Investments changed N/A year-over-year to $2224.0; the trailing twelve-month figure through Mar 2025 stood at $2224.0 (changed N/A YoY), and the FY2024 full-year result was $2224.0, down 63.23% from the prior year.
• Long-Term Investments held at $2224.0 in Q1 2025, from $2224.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $827612.0 in Q4 2022 to a low of $2224.0 in Q4 2024.
• A 5-year average of $250710.2 and a median of $5987.5 in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments grew 25.35% in 2022 and slumped 99.27% in 2023, its largest moves.
• Tracing QNTM's Long-Term Investments over 5 years: stood at $660226.0 in 2021, then climbed by 25.35% to $827612.0 in 2022, then tumbled by 99.27% to $6049.0 in 2023, then sank by 63.23% to $2224.0 in 2024, then changed by 0.0% to $2224.0 in 2025.
• Business Quant data shows QNTM's Long-Term Investments at $2224.0 in Q1 2025, $2224.0 in Q4 2024, and $5926.0 in Q3 2024.